Cocrystal Pharma (COCP) Treasury Shares (2014 - 2026)
Cocrystal Pharma (COCP) reported Treasury Shares of $221000.0 for Q1 2026, up 42.58% on a YoY basis from $155000.0 in Q1 2025, and up 127.84% sequentially from $97000.0 in Q4 2025.
Cocrystal Pharma (COCP) Treasury Shares (2014 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 9 years of Treasury Shares data on file, last reported at $221000.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 42.58% year-over-year to $221000.0; the trailing twelve-month figure through Mar 2026 stood at $221000.0 (up 42.58% YoY), and the FY2025 full-year result was $97000.0, down 62.11% from the prior year.
- Treasury Shares rose to $221000.0 in Q1 2026, from $97000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $256000.0 in Q4 2024 to a low of $97000.0 in Q4 2025.
- A 3-year average of $165857.1 and a median of $155000.0 in 2025 frame the typical range for Treasury Shares.
- Across the five-year window, Treasury Shares tumbled 62.11% in 2025 and soared 42.58% in 2026, its largest moves.
- Tracing COCP's Treasury Shares over 3 years: stood at $256000.0 in 2024, then plunged by 62.11% to $97000.0 in 2025, then jumped by 127.84% to $221000.0 in 2026.
- Business Quant data shows COCP's Treasury Shares at $221000.0 in Q1 2026, $97000.0 in Q4 2025, and $113000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 221,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 155,000.00 |
| Jun 30, 2025 | 155,000.00 |
| Mar 31, 2025 | 155,000.00 |
| Mar 31, 2025 | 155,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Dec 31, 2018 | 243,000.00 |
| Dec 31, 2018 | 243,000.00 |
| Sep 30, 2018 | 243,000.00 |
| Sep 30, 2018 | 243,000.00 |